Improving Prescribing Rates of Glucagon-Like Peptide 1 Receptor Agonists in Youth With Type 2 Diabetes

Quality Improvement Success Stories are published by the American Diabetes Association in collaboration with the American College of Physicians and the National Diabetes Education Program. This series is intended to highlight best practices and strategies from programs and clinics that have successfully improved the quality of care for people with diabetes or related conditions. Each article in the series is reviewed and follows a standard format developed by the editors of <i>Clinical Diabetes</i>. The following article describes a quality improvement project to improve outcomes by increasing the prescribing rates of GLP-1 receptor agonists in pediatric patients with type 2 diabetes in the pediatric endocrinology clinics of a Seattle, WA-based health care system.